While Takeda's Qdenga (TAK-003) shot is approved as a two-dose regimen to protect people from the disease in dozens of countries around the world, the drugmaker withdrew its FDA filing in mid-2023 ...

Merck , known as MSD outside of the United States and Canada, today announced the initiation of the MOBILIZE-1 Phase 3 clinical trial evaluating the safety, immunogenicity and efficacy of a single ...

Merck & Co Inc (NYSE:MRK) has begun a Phase 3 clinical trial to test its experimental dengue vaccine in a pediatric ...

Hospital authorities confirmed that 79 patients were admitted with dengue in the last 24 hours, taking the total number of hospitalised dengue patients in the district to 172 as of yesterday evening ...

Special Report: Antiviral drug development company Island Pharmaceuticals is forging ahead after reporting top-line results from its Phase 2a/b PROTECT Trial using ISLA-101 in a human challenge model ...

Island Pharmaceuticals Ltd has announced successful results from its Phase 2a/b clinical trial of ISLA-101, an antiviral drug aimed at combating dengue virus. The trial demonstrat ...

Sri Lanka is currently facing a grave public health crisis as the country has been witnessing a surge in the number of ...